Mature results of a phase III randomized trial of bacillus Calmette-Guerin (BCG) versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer Stage I-III melanoma (E1673): a trial of the Eastern Oncology Group.

Mature results of a phase III randomized trial of bacillus Calmette-Guerin (BCG) versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer Stage I-III melanoma (E1673): a trial of the Eastern Oncology Group. Cancer. 2004 Apr 15; 100(8):1692-8.

View in: PubMed

subject areas

Adjuvants, Immunologic
Adult
Aged
Antineoplastic Agents, Alkylating
BCG Vaccine
Chemotherapy, Adjuvant
Combined Modality Therapy
Dacarbazine
Disease Progression
Drug Therapy, Combination
Female
Humans
Male
Melanoma
Middle Aged
Skin Neoplasms
Survival Analysis
Treatment Outcome

authors with profiles

JOHN KIRKWOOD